New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics

September 2015

Welcome to the September 2015 issue of PharmSource PERISCOPE

This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.

Enjoy the September issue!

The PharmSource Team

 

PharmSource Lead Sheet Global Activity Report:

Lead Type August 2015 2015 YTD
Early Development 92 939
Late Development 85 825
Biologic 81 722
Small Molecule 187 1840
Parenteral 79 824
Oral 80 749
New Financings 85 762
Total Drug Leads 364 3128
Total Device &
Diagnostic Leads
153 1089

*Total leads include acquisitions/alliances, company acquisition/alliances and events.


 

Pipeline Tip

RXi Pharmaceuticals plans to initiate a Phase I/II trial in Q4 of 2015 with RXI-109 to prevent progression of the scarring component of retinal diseases:

  • Therapeutic Area: Ophthalmology
  • Dosage Form: Parenteral
  • API: Nucleic acid – RNA
  • Learn more
     

    Map Feature Shows Facility Locations, Gives Driving Directions

    by Blythe Moore, Director of Account Management

    I’m excited to tell you about the latest enhancement we’ve added to your PharmSource Lead Sheet: a map feature!

    The new map feature lets you easily find pharma and biotech company locations. Just click on map pins, which are located throughout the system, including on the weekly issue. You can zoom to street level, and even… read on
     

    Follow the Money: Genocea Biosciences Inc.

    Genocea Biosciences Inc. is a U.S. public pharmaceutical company that discovers, develops and commercializes vaccines based on the discovery of antigens that induce T cell immunity. Genocea expects to raise $50 million in the completion of a secondary public offering.

    What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support clinical development of these drug candidates… read on
     

    Direct ClinicalTrials.gov Links in Lead Sheet Bring Ancillary Info

    by Blythe Moore, Director of Account Management

    We had a very busy summer here at PharmSource! In addition to adding a map feature, the PharmSource Lead Sheet now has direct links from drug product candidates to ClinicalTrials.gov, when available.

    You’ll find these links in the blue box to the right of each lead, along with the product characteristics, and also in Excel downloads.

    ClinicalTrials.gov is a resource for doctors and patients to identify clinical studies. While not a BD resource in itself, the database may provide… read on
     

    New Report Available: PharmSource CMO Industry Analysis

    Our just-released 2015 Contract Dose Manufacturing Industry by the Numbers report is an indispensable resource for understanding the competitive environment faced by dose manufacturers, and provides critical insights for your strategic planning efforts. The report will enable you to:

    • Benchmark your performance against other CMOs in the industry
    • Understand what strategies CMOs are pursuing for profitable growth
    • Grasp CMO business challenges affecting bio/pharmaceutical negotiations

    Thanks to our deep expertise and ongoing research, Contract Dose Manufacturing Industry by the Numbers is the most authoritative and reliable portrait of the CMO industry available to the bio/pharmaceutical industry today.

    Our proprietary model and assumptions are fully explained so you can understand how we arrived at our analysis and conclusions.

    You won’t find this mission-critical information in any other source. Click here for more information or to order this report today.
     

    Looking for Drug and Device Combinations?

    We recently were asked where to find drugs that are delivered by medical devices. These are reported in the Drug Edition of the PharmSource Lead Sheet. We follow the changing status of these drugs as they go through the clinical trial process, and describe the delivery device in the comment section. These are usually identified as having a “Proprietary device” dosage form, and may be broken down further into “Inhaled – Proprietary device” or “Parenteral – Proprietary device.”

    If you’re not sure where to find something in the Lead Sheet, just let us know. Support is included as an integral part of your subscription! Contact Blythe Moore, our Director of Account Management at +1.703.383.4903, ext. 104, or blythe.moore@pharmsource.com.
     

    PharmSource President Jim Miller
    to Speak at Two Industry Events

    Contract Pharma: 14th Annual Conference and Tabletop Exhibition.
    New Brunswick, New Jersey
    Thursday, September 17 at 2:15pm

    CPhI Worldwide: Pharma Insight Briefings.
    Madrid, Spain
    Wednesday, October 14 at 12pm
     

    PharmSource Lead Sheet

    The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.

    Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.

    See for yourself how this resource can be a vital tool for building your brand and growing your market share.

    To request a test-drive today, contact Nathaniel Celentano at nathaniel@pharmsouce.com / 1-703-383-4903, ext. 112 (ET USA).